metastatic spread and drug chemoresistance. Hence there is a need for new approaches to
either increase the efficacy of current therapy or introduce new therapies that have greater
efficacy. There is increasing evidence that dysregulation of WNT-signaling-pathway plays an
essential role in the development and prognosis of CRC. Here we have investigated the
therapeutic potential of targeting the WNT/b-catenin pathway using a novel Wnt/b-catenin …